Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label ; NICE; CA125. Show all posts
Showing posts with label ; NICE; CA125. Show all posts
Wednesday, February 22, 2012

abstract: Risk of Malignancy in Sonographically Confirmed Ovarian Tumors

›
Abstract Ovarian cancer is the leading cause of gynecologic cancer death in the United States. Once an ovarian tumor is identified, a...
Wednesday, February 08, 2012

abstract: Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with Bevacizumab (Avastin) Gynecologic Oncology Group phase II trial

›
Purpose To compare two methods of determining therapeutic response and disease progression — modified Gynecologic Cancer Intergroup (...
Friday, January 27, 2012

abstract: Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.

›
Abstract " The validation of prognostic biomarkers in large independent patient cohorts is a major bottleneck in ovarian cancer re...
Tuesday, January 10, 2012

UK - Ovarian cancer test news is misunderstood says gynaecological cancer charity The Eve Appeal | CA125/NICE guidelines

›
"In light of recent media coverage following the introduction of new NICE guidelines on ovarian cancer , The Eve Appeal and UCL Gynaec...
Sunday, January 01, 2012

Follow-up with CA125 after primary therapy of adva... [Ann Oncol. 2011] - PubMed - NCBI

›
CONCLUSIONS: Women should be advised not to have routine CA125 measurements, providing they are well and have no symptoms suggesting re...
1 comment:
Saturday, May 28, 2011

Editorial - no abstract/pay-per-view: - Gynecologic Oncology : More than a biomarker: CA125 may contribute to ovarian cancer pathogenesis

›
Abstract Gynecologic Oncology Volume 121, Issue 3 , 1 June 2011, Pages 429-430 Editorial More than a biom...
Saturday, May 14, 2011

Editorial: New guidelines for early detection of ovarian cancer : The Lancet

›
"....NICE advises primary care professionals to measure serum concentrations of the protein CA125 if a woman (especially if older than...